Vozarova, B. et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51, 1889–1895 (2002).
Doi, Y. et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: The Hisayama study. Obesity 15, 1841–1850 (2007).
Sato, K. K. et al. Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care 31, 1230–1236 (2008).
Kunutsor, S. K., Apekey, T. A. & Walley, J. Liver aminotransferases and risk of incident type 2 diabetes: A systematic review and meta-analysis. Am. J. Epidemiol. 178, 159–171 (2013).
Gastaldelli, A. & Cusi, K. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. JHEP Rep. 1, 312–328 (2019).
Khan, R. S., Bril, F., Cusi, K. & Newsome, P. N. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology 70, 711–724 (2019).
Fuyan, S. et al. Fatty liver disease index: A simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population. Dig. Dis. Sci. 58, 3326–3334 (2013).
Lee, J. H. et al. Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42, 503–508 (2010).
Long, M. T. et al. Development and validation of the Framingham steatosis index to identify persons with hepatic steatosis. Clin. Gastroenterol. Hepatol. 14, 1172-1180.e2 (2016).
Lu, C. W. et al. Aminotransferase ratio is a useful index for hepatosteatosis in children and adolescents: A cross-sectional observational study. Gastroenterol. Nurs. 42, 486–495 (2019).
Lin, M. S. et al. Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: A cross-sectional observational study. BMJ Open 5, e008797. https://doi.org/10.1136/bmjopen-2015-008797 (2015).
Zou, Y., Zhong, L., Hu, C. & Sheng, G. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: A population-based longitudinal study. Lipids Health Dis. 19, 245. https://doi.org/10.1186/s12944-020-01419-z (2020).
Olaogun, I., Farag, M. & Hamid, P. The pathophysiology of type 2 diabetes mellitus in non-obese individuals: An overview of the current understanding. Cureus. 12, e7614. https://doi.org/10.7759/cureus.7614 (2020).
Tsuboi, A. et al. Higher circulating orosomucoid, an acute-phase protein, and reduced glucose-induced insulin secretion in middle-aged Japanese people with prediabetes. BMJ Open Diabetes Res. Care. 8, e001392. https://doi.org/10.1136/bmjdrc-2020-001392 (2020).
Luo, Z. et al. Orosomucoid, an acute response protein with multiple modulating activities. J. Physiol. Biochem. 71, 329–340 (2015).
Takeuchi, M. et al. Weight trajectory since birth, current body composition, dietary intake, and glucose tolerance in young underweight Japanese women. Womens Health Rep. 3, 215–221 (2022).
Tanaka, S. et al. Associations of lower-body fat mass with favorable profile of lipoproteins and adipokines in healthy, slim women in early adulthood. J. Atheroscler. Thromb. 18, 365–372 (2011).
Tanaka, M. et al. FTO, abdominal adiposity, fasting hyperglycemia associated with elevated HbA1c in Japanese middle-aged women. J. Atheroscler. Thromb. 19, 633–642 (2012).
Cheng, S. et al. Adipose tissue dysfunction and altered systemic amino acid metabolism are associated with non-alcoholic fatty liver disease. PLoS ONE 10, e0138889. https://doi.org/10.1371/journal.pone.0138889 (2015).
Bao, X. et al. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: A prospective study exploring the “common soil” hypothesis. Cardiovasc. Diabetol. 17, 87. https://doi.org/10.1186/s12933-018-0733-9 (2018).
Matthews, D. R. et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985).
Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462–1470 (1999).
Stumvoll, M. et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295–301 (2000).
American Diabetes Association 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care 41, S1327 (2018).
Tsuboi, A. et al. Association of serum orosomucoid with 30-min plasma glucose and glucose excursion during oral glucose tolerance tests in non-obese young Japanese women. BMJ Open Diabetes Res. Care. 6, e000508. https://doi.org/10.1136/bmjdrc-2018-000508 (2018).
Stefan, N., Kantartzis, K. & Häring, H. U. Causes and metabolic consequences of fatty liver. Endocr. Rev. 29, 939–960 (2008).
Kawamoto, R. et al. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc. Diabetol. 11, 117. https://doi.org/10.1186/1475-2840-11-117 (2012).
Zhao, L. et al. Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population. Nutr. Metab. 14, 64. https://doi.org/10.1186/s12986-017-0219-x (2017).
Kwon, S. S. & Lee, S. G. A high alanine aminotransferase/aspartate aminotransferase ratio determines insulin resistance and metabolically healthy/unhealthy obesity in a general adult population in Korea: The Korean National Health and Nutritional Examination Survey 2007–2010. Exp. Clin. Endocrinol. Diabetes. 127, 677–684 (2019).
Pinnaduwage, L. et al. Changes over time in hepatic markers predict changes in insulin sensitivity, β-cell function, and glycemia. J. Clin. Endocrinol. Metab. 103, 2651–2659 (2018).
Song, S. et al. ALT/AST as an independent risk factor of gestational diabetes mellitus compared with TG/HDL-C. Int. J. Gen. Med. 15, 115–121 (2022).
Gasevic, D., Frohlich, J., Mancini, G. B. & Lear, S. A. The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort. Metabolism 61, 583–589 (2012).
Masroor, M. & Haque, Z. HbA1C as a biomarker of non-alcoholic fatty liver disease: Comparison with anthropometric parameters. J. Clin. Transl. Hepatol. 9, 15–21 (2021).
Xie, Y., Kong, W., Wang, X. & Wu, Z. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes. BMC Endocr. Disord. 22, 220. https://doi.org/10.1186/s12902-022-01134-z (2022).
Luo, Y. et al. Role of liquid fructose/sucrose in regulating the hepatic transcriptome in a high-fat Western diet model of NAFLD. J. Nutr. Biochem. 112, 109174. https://doi.org/10.1016/j.jnutbio.2022.109174 (2023).
Abdullah, A. R., Hasan, H. A. & Raigangar, V. L. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. Metab. Syndr. Relat. Disord. 7, 17–22 (2009).